These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8809591)

  • 41. Immunocytochemistry of pancreatic endocrine tumors in three domestic ferrets (Mustela putorius furo).
    Fix AS; Harms CA
    Vet Pathol; 1990 May; 27(3):199-201. PubMed ID: 1972304
    [No Abstract]   [Full Text] [Related]  

  • 42. Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumour causing severe hypercalcaemia.
    Müssig K; Petersenn S; Wehrmann M; Horger M; Vierling P; Häring HU; Gallwitz B
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):719-23. PubMed ID: 17625444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Portal and pancreatic vein catheterization with radioimmunologic determination of insulin.
    Ingemansson S; Lunderquist A; Lundquist I; Lövdahl R; Tibblin S
    Surg Gynecol Obstet; 1975 Nov; 141(5):705-11. PubMed ID: 173031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glucagon-secreting pancreatic islet cell carcinoma, containing insulin and somatostatin, with hypoglycemic attack.
    Yano T; Yamamoto N; Fujimori K; Inamori S; Hayashi H; Mizumoto R
    Am J Gastroenterol; 1982 Jun; 77(6):387-91. PubMed ID: 6124121
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Paraneoplastic syndromes in cancer: Case 3. Parathyroid hormone-related hypercalcemia in cholangiocarcinoma.
    Yen Y; Chu PG; Feng W
    J Clin Oncol; 2004 Jun; 22(11):2244-5. PubMed ID: 15169815
    [No Abstract]   [Full Text] [Related]  

  • 46. Majority and minority cell populations in GEP and bronchial endocrine tumours.
    Sundler F; Alumets J; Håkanson R
    Scand J Gastroenterol Suppl; 1979; 53():9-13. PubMed ID: 225792
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Ectopic ACTH syndrome].
    Kasperlik-Załuska A; Rosłonowska E; Migdalska B; Jeske W; Drac-Kaniewska J; Nowakowski J; Zgliczyński W; Załuska J
    Pol Arch Med Wewn; 1987 Dec; 78(6):355-62. PubMed ID: 2855943
    [No Abstract]   [Full Text] [Related]  

  • 48. [Endocrine (secreting and apparently inert) tumors of the pancreas].
    Bougha P
    J Ont Dent Assoc; 1971 May; 48(5):853-63. PubMed ID: 4325897
    [No Abstract]   [Full Text] [Related]  

  • 49. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
    Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
    J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Editorial: Hypoglycemic digestive tumors].
    Laurent J; Heully F; Debry G
    Arch Fr Mal App Dig; 1973 Sep; 62(6):445-8. PubMed ID: 4779226
    [No Abstract]   [Full Text] [Related]  

  • 51. Medical management of secretory syndromes related to gastroenteropancreatic neuroendocrine tumours.
    Dimitriadis GK; Weickert MO; Randeva HS; Kaltsas G; Grossman A
    Endocr Relat Cancer; 2016 Sep; 23(9):R423-36. PubMed ID: 27461388
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metachronous hormonal syndromes in patients with pancreatic neuroendocrine tumors: a case-series study.
    de Mestier L; Hentic O; Cros J; Walter T; Roquin G; Brixi H; Lombard-Bohas C; Hammel P; Diebold MD; Couvelard A; Ruszniewski P; Cadiot G
    Ann Intern Med; 2015 May; 162(10):682-9. PubMed ID: 25984844
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Metastasizing, endocrine active pancreatic tumor with hormone conversion from gastrin to insulin].
    Czermak H; Fortunat W; Schernthaner G
    Wien Med Wochenschr; 1987 Jun; 137(12):273-4. PubMed ID: 3303702
    [No Abstract]   [Full Text] [Related]  

  • 54. [PTH-related protein producing tumor].
    Okazaki T
    Nihon Rinsho; 2006 Sep; Suppl 3():317-23. PubMed ID: 17022555
    [No Abstract]   [Full Text] [Related]  

  • 55. Necrolytic migratory erythema: a common cutaneous clue of uncommon syndromes.
    Stavropoulos PG; Papafragkaki DK; Avgerinou G; Papafragkakis H; Katsavou A; Katsambas AD
    Cutis; 2013 Nov; 92(5):E1-4. PubMed ID: 24343217
    [No Abstract]   [Full Text] [Related]  

  • 56. Somatostatin inhibition of insulin and gastrin hypersecretion in pancreatic islet-cell carcinoma.
    Curnow RT; Carey RM; Taylor A; Johanson A; Murad F
    N Engl J Med; 1975 Jun; 292(26):1385-6. PubMed ID: 166308
    [No Abstract]   [Full Text] [Related]  

  • 57. Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects.
    Gola M; Doga M; Bonadonna S; Mazziotti G; Vescovi PP; Giustina A
    Pituitary; 2006; 9(3):221-9. PubMed ID: 17036195
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Hormonally-active tumors of the pancreas (lecture)].
    Kalinin AP; Radbil" OS; Nurmanbetov DN
    Probl Endokrinol (Mosk); 1986; 32(2):40-6. PubMed ID: 3012513
    [No Abstract]   [Full Text] [Related]  

  • 59. [The somatostatin receptor family--a window against new diagnosis and therapy of cancer].
    Hofsli E
    Tidsskr Nor Laegeforen; 2002 Feb; 122(5):487-91. PubMed ID: 11961977
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple endocrine neoplasia type 1 associated with a new mutation in the menin gene and a midgut neuroendocrine tumor.
    Agarwal R; Szalkiewicz ER; Warner RR; Roayaie S; Hechtman JF; Zhu H; Kim MK
    Pancreas; 2014 Jan; 43(1):145-6. PubMed ID: 24326372
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.